Furthermore, SPTBN1 expression is reduced in early stage CRC and that of Smad4 in advanced carcinomas, which indicates a key role for SPTBN1/Smad4/TGF-β signaling in the suppression of cancer progression [119]. This evidence concerns the gene SPTBN1 and colorectal carcinoma.